REGN - REGENERON PHARMACEUTICALS, INC.

QQQ $ 612.14 $ 1.56 (0.26 %)

DIA $ 470.45 $ 1.64 (0.35 %)

SPY $ 672.31 $ 2.95 (0.44 %)

TLT $ 89.45 $ -0.19 (-0.21 %)

GLD $ 367.77 $ 0.35 (0.1 %)

Previous Close

$ 657.53

Open

$ 650.35

Bid

$ 650.00 x 1

Ask

$ 657.17 x 2

Day's Range

$ 640.99 - $ 658.21

52 Week Range

$ 475.76 - $ 830.86

Volume

782,810

Average Volume

Market Cap

69.11B

Beta (5Y Monthly)

$ 0.71

PE Ratio (TTM)

$ 15.10

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	10-28-2025	09-30-2025	10-Q
2	08-01-2025	06-30-2025	10-Q
3	04-29-2025	03-31-2025	10-Q
4	02-05-2025	12-31-2024	10-K
5	10-31-2024	09-30-2024	10-Q
6	08-01-2024	06-30-2024	10-Q
7	05-02-2024	03-31-2024	10-Q
8	02-05-2024	12-31-2023	10-K
9	11-02-2023	09-30-2023	10-Q
10	08-03-2023	06-30-2023	10-Q
11	05-04-2023	03-31-2023	10-Q
12	02-06-2023	12-31-2022	10-K
13	11-03-2022	09-30-2022	10-Q
14	08-03-2022	06-30-2022	10-Q
15	05-04-2022	03-31-2022	10-Q
16	02-07-2022	12-31-2021	10-K
17	11-04-2021	09-30-2021	10-Q
18	08-05-2021	06-30-2021	10-Q
19	05-06-2021	03-31-2021	10-Q
20	02-08-2021	12-31-2020	10-K
21	11-05-2020	09-30-2020	10-Q
22	08-05-2020	06-30-2020	10-Q
23	05-05-2020	03-31-2020	10-Q
24	02-07-2020	12-31-2019	10-K
25	11-05-2019	09-30-2019	10-Q
26	08-06-2019	06-30-2019	10-Q
27	05-07-2019	03-31-2019	10-Q
28	02-07-2019	12-31-2018	10-K
29	11-06-2018	09-30-2018	10-Q
30	08-02-2018	06-30-2018	10-Q
31	05-03-2018	03-31-2018	10-Q
32	02-08-2018	12-31-2017	10-K
33	11-08-2017	09-30-2017	10-Q
34	08-03-2017	06-30-2017	10-Q
35	05-04-2017	03-31-2017	10-Q
36	02-09-2017	12-31-2016	10-K
37	11-04-2016	09-30-2016	10-Q
38	08-04-2016	06-30-2016	10-Q
39	05-05-2016	03-31-2016	10-Q
40	02-11-2016	12-31-2015	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

UBS Maintains Neutral on Regeneron Pharmac...
11/07/2025 17:52:48

UBS analyst Trung Huynh maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a Neutral and raises the price target from $5...

Regeneron Pharmaceuticals Trial Data From ...
11/07/2025 13:11:51

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced the presentation of positive results from the pivotal...

Regeneron PResents Results Showing LIBERTY...
11/07/2025 13:08:00

Here's How Much You Would Have Made Owning...
11/06/2025 15:30:59

Looking Into Regeneron Pharmaceuticals Inc...
11/04/2025 19:00:36

michael-burry-is-super-bearish-on-palantir--with-5-million-puts

Michael Burry Is Super-Bearish On Palantir...
11/03/2025 23:17:30

Michael Burry's Scion Asset Management filed an updated 13F showing a new large bearish position in Palantir and Nvidia, am...

RBC Capital Maintains Sector Perform on Re...
10/29/2025 16:56:39

RBC Capital analyst Brian Abrahams maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a Sector Perform and raises the pr...

Wells Fargo Maintains Equal-Weight on Rege...
10/29/2025 14:16:08

Wells Fargo analyst Mohit Bansal maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a Equal-Weight and raises the price ...

Cantor Fitzgerald Maintains Overweight on ...
10/29/2025 13:50:33

Cantor Fitzgerald analyst Carter Gould maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a Overweight and raises the pr...

Guggenheim Maintains Buy on Regeneron Phar...
10/29/2025 12:46:20

Guggenheim analyst Yatin Suneja maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a Buy and raises the price target fro...

B of A Securities Maintains Underperform o...
10/29/2025 12:06:41

B of A Securities analyst Tim Anderson maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a Underperform and raises the ...

ModeX Therapeutics Enters License, Collabo...
10/29/2025 12:02:41

ModeX Therapeutics Inc., an OPKO Health company (NASDAQ: OPK), today announced that it has entered into a license and collabora...

nasdaq-100-hits-26000-gold-falls-below-4000-whats-moving-markets-tuesday

Nasdaq 100 Hits 26,000, Gold Falls Below $...
10/28/2025 17:23:51

Tech stocks hit new highs as the Nasdaq 100 rallies 0.7% midday. Investors eye a Fed rate cut, Trump-Xi meeting, and major tech...

wayfair-qorvo-celestica-united-parcel-service-regeneron-pharmaceuticals-and-other-big-stocks-moving-higher-on-tuesday

Wayfair, Qorvo, Celestica, United Parcel S...
10/28/2025 14:14:02

regenerons-q3-earnings-outperform-expectations-with-dupixent-strength-balancing-eylea-weakness

Regeneron's Q3 Earnings Outperform Expecta...
10/28/2025 13:13:27

Regeneron posts Q3 earnings of $11.83 per share, topping estimates as Dupixent profits lift results despite weaker Eylea sales.

Earnings Scheduled For October 28, 2025
10/28/2025 11:11:34

Regeneron Pharmaceuticals Q3 Adj. EPS $11....
10/28/2025 10:30:38

Regeneron Pharmaceuticals (NASDAQ:REGN) reported quarterly earnings of $11.83 per share which beat the analyst consensus estima...

A Preview Of Regeneron Pharmaceuticals's E...
10/27/2025 15:01:00

Here's How Much $1000 Invested In Regenero...
10/20/2025 16:14:58

fda-unveils-first-experimental-drugs-under-fast-track-voucher-plan-to-cut-drug-review-times

FDA Unveils First Experimental Drugs Under...
10/17/2025 14:03:18

The FDA launched a new voucher program to fast-track reviews, naming nine experimental drugs for cancer, diabetes, addiction, a...